Using artificial neural networks to drive virtual screening of combinatorial libraries

Drug Discovery Today: BIOSILICO

Volumn 2, Issue 4, 2004, Pages 149-156

  Lobanov, Victor ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

artificial neural networks; Bioinformatics; Drug Discovery; in silico screening; Techniques Methods; virtual combinatorial libraries

Indexed keywords

ARTIFICIAL NEURAL NETWORK; COMBINATORIAL CHEMISTRY; COMPUTER MODEL; DRUG INDUSTRY; HIGH THROUGHPUT SCREENING; LIPOPHILICITY; REVIEW; TECHNIQUE; VIRTUAL REALITY;

EID: 12344276385     PISSN: 17418364     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1741-8364(04)02402-3     Document Type: Review

References (82)

1. Bleicher K., et al. Hit and lead generation: beyond high-throughput screening. Nat. Rev. Drug Discov. 2:2003;369-378
2. Stahl M., Rarey M. Detailed analysis of scoring functions for virtual screening. J. Med. Chem. 44:2001;1035-1042
3. Lobanov V.S., Agrafiotis D.K. Scalable methods for the construction and analysis of virtual combinatorial libraries. Combin. Chem. High Throughput Screen. 5:2002;167-178
4. Agrafiotis D.K. Multiobjective optimization of combinatorial libraries. Mol. Divers. 5:2002;209-230
5. Manly C.J., et al. The impact of informatics and computational chemistry on synthesis and screening. Drug Discov. Today. 6:2001;1101-1110
6. Taskinen J., Yliruusi J. Prediction of physicochemical properties based on neural network modelling. Adv. Drug Deliv. Rev. 55:2003;1163-1183
7. Haykin S. Neural Networks. 1994;Prentice-Hall
8. Gasteiger J., Zupan J. Neural networks in chemistry. Angew. Chem. Int. Ed. Engl. 32:1993;503-527
9. Winkler D.A., Madellena D.J. QSAR and neural networks in life sciences. Ser. Math. Biol. Med. 5:1994;126-163
10. Devillers J. Neural Networks in Qsar and Drug Design. 1996;Academic Press
11. Schneider G., Wrede P. Artificial neural networks for computer-based molecular design. Prog. Biophys. Mol. Biol. 70:1998;175-222
12. Zupan J., Gasteiger J. Neural Networks in Chemistry and Drug Design. 2nd edn:1999;Wiley-VCH
13. Schneider G. Neural networks are useful tools for drug design. Neural Netw. 13:2000;15-16
14. Ichikawa H. Hierarchy neural networks as applied to pharmaceutical problems. Adv. Drug Deliv. Rev. 55:2003;1119-1147
15. Kohonen T. 3rd edn Self-Organizing Maps. Vol. 30:2000;Springer Series in Information Sciences, Springer-Verlag
16. Polanski J. Self-organizing neural networks for pharmacophore mapping. Adv. Drug Deliv. Rev. 55:2003;1149-1162
17. Brüstle M., et al. Descriptors, physical properties, and drug-likeness. J. Med. Chem. 45:2002;3345-3355
18. Ajay A., et al. Can we learn to distinguish between 'drug-like' and 'nondrug-like' molecules? J. Med. Chem. 41:1998;3314-3324
19. Burden F., Winkler D.A. New QSAR methods applied to structure-activity mapping and combinatorial chemistry. J. Chem. Inf. Comput. Sci. 39:1999;236-242
20. Burden F.R., Winkler D.A. Robust QSAR models using bayesian regularized neural networks. J. Med. Chem. 42:1999;3183-3187
21. Reed R.D., Marks R.J. II. Neural Smithing: Supervised Learning in Feedforward Artificial Neural Networks. 1999;MIT Press
22. Brown R., Martin Y. Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection. J. Chem. Inf. Comput. Sci. 36:1996;572-584
23. Todeschini R., et al. Handbook of Molecular Descriptors. 2000;Wiley-VCH
24. Brown R., Martin Y. The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding. J. Chem. Inf. Comput. Sci. 37:1997;1-9
25. Huuskonen J. Estimation of aqueous solubility for a diverse set of organic compounds based on molecular topology. J. Chem. Inf. Comput. Sci. 40:2000;773-777
26. Liu R., So S-S. Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 1. aqueous solubility. J. Chem. Inf. Comput. Sci. 41:2001;1633-1639
27. Tetko I.V. Estimation of aqueous solubility of chemical compounds using E-state indices. J. Chem. Inf. Comput. Sci. 41:2001;1488-1493
28. Tetko I.V., Tanchuk V.Yu. Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program. J. Chem. Inf. Comput. Sci. 42:2002;1136-1145
29. Engkvist O., Wrede P. High-throughput, in silico prediction of aqueous solubility based on one- and two-dimensional descriptors. J. Chem. Inf. Comput. Sci. 42:2002;1247-1249
30. Takaoka Y., et al. Development of a method for evaluating drug-likeness and ease of synthesis using a data set in which compounds are assigned scores based on chemists' intuition. J. Chem. Inf. Comput. Sci. 43:2003;1269-1275
31. Sadowski J., Kubinyi H. A scoring scheme for discriminating between drugs and nondrugs. J. Med. Chem. 41:1998;3325-3329
32. Baurin, N. et-al. 2D QSAR consensus prediction for high-throughput virtual screening. An application to COX-2 inhibition modeling and screening of the NCI database. J. Chem. Inf. Comput. Sci. (in press)
33. Manallack D.T., et al. Selecting screening candidates for kinase and G-protein-coupled receptor targets using neural networks. J. Chem. Inf. Comput. Sci. 42:2002;1256-1262
34. Agrafiotis D.K., et al. Combinatorial informatics in post-genomics era. Nat. Rev. Drug Discov. 1:2002;337-346
35. Yaffe D., et al. A fuzzy ARTMAP based on quantitative structure-property relationships (QSPRs) for predicting aqueous solubility of organic compounds. J. Chem. Inf. Comput. Sci. 41:2001;1177-1207
36. Yan A., Gasteiger J. Prediction of aqueous solubility of organic compounds based on a 3D structure representation. J. Chem. Inf. Comput. Sci. 43:2003;429-434
37. Livingstone D.J., Manallack D.T. Neural networks in 3D QSAR. QSAR Comb. Sci. 22:2003;510-518
38. Leach A.R., Hann M.M. The in silico world of virtual libraries. Drug Discov. Today. 5:2000;326-336
39. Willett P., et al. Chemical similarity searching. J. Chem. Inf. Comput. Sci. 38:1998;983-996
40. Chiu T-L., So S-S. Genetic neural networks for functional approximation. QSAR Comb. Sci. 22:2003;519-526
41. Ajay A., et al. Designing libraries with CNS activity. J. Med. Chem. 42:1999;4942-4951
42. Yasri A., Hartsough D. Toward an optimal procedure for variable selection and QSAR model building. J. Chem. Inf. Comput. Sci. 41:2001;1218-1227
43. Balakin K.V., et al. Property-based design of GPCR-targeted library. J. Chem. Inf. Comput. Sci. 42:2002;1332-1342
44. Balakin, K.V. et-al. Structure-based versus property-based approaches in the design of G-protein-coupled receptor-targeted libraries. J. Chem. Inf. Comput. Sci. (in press)
45. So S-S., et al. Quantitative structure-activity relationship studies of progesterone receptor binding steroids. J. Chem. Inf. Comput. Sci. 40:2000;762-772
46. Mattioni B.E., Jurs P.C. Development of quantitative structure-activity relationship and classification models for a set of carbonic anhydrase inhibitors. J. Chem. Inf. Comput. Sci. 42:2002;94-102
47. Patankar S.J., Jurs P.C. Prediction of glycine/NMDA receptor antagonist inhibition from molecular structure. J. Chem. Inf. Comput. Sci. 42:2002;1053-1068
48. Viswanadhan V.N., et al. Comparison of a neural net-based QSAR algorithm (PCANN) with hologram- and multiple linear regression-based QSAR approaches: application to 1,4-dihydropyridine-based calcium channel antagonists. J. Chem. Inf. Comput. Sci. 41:2001;505-511
49. Hemmateenejad B., et al. Genetic algorithm applied to the selection of factors in principal component-artificial neural networks: application to QSAR study of calcium channel antagonist activity of 1,4-dihydropyridines (nifedipine analogous). J. Chem. Inf. Comput. Sci. 43:2003;1328-1334
50. Burden F.R., et al. Use of automatic relevance determination in QSAR studies using Bayesian neural networks. J. Chem. Inf. Comput. Sci. 40:2000;1423-1430
51. Rabow A.A., et al. Mining the National Cancer Iinstitute's tumor-screening database: identification of compounds with similar cellular activities. J. Med. Chem. 45:2002;818-840
52. 2A) antagonists using self-organizing maps. J. Comb. Chem. 5:2003;233-237
53. Polanski J., Gieleciak R. Comparative molecular surface analysis: a novel tool for drug design and molecular diversity studies. Mol. Divers. 7:2003;45-59
54. Lipinski C.A., et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23:1997;3-25
55. Walters W.P., Murcko M.A. Prediction of 'drug-likeness'. Adv. Drug Deliv. Rev. 54:2002;255-271
56. Murcia-Soler M., et al. Drugs and nondrugs: an effective discrimination with topological methods and artificial neural networks. J. Chem. Inf. Comput. Sci. 43:2003;1688-1702
57. van de Waterbeemd H., Gifford E. ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov. 2:2003;192-204
58. Jorgensen W.L., Duffy E.M. Prediction of drug solubility from structure. Adv. Drug Deliv. Rev. 54:2002;355-366
59. Bruneau P. Search for predictive generic model of aqueous solubility using Bayesian neural nets. J. Chem. Inf. Comput. Sci. 41:2001;1605-1616
60. Erös D., et al. Reliability of logP predictions based on calculated molecular descriptors: a critical review. Curr. Med. Chem. 9:2002;1819-1829
61. Wegner J.K., Zell A. Prediction of aqueous solubility and partition coefficient optimized by a genetic algorithm based descriptor selection method. J. Chem. Inf. Comput. Sci. 43:2003;1077-1084
62. Yaffe D. Fuzzy ARTMAP and back-propagation neural networks based quantitative structure-property relationships (QSPRs) for octanol-water partition coefficient of organic compounds. J. Chem. Inf. Comput. Sci. 42:2002;162-183
63. Egan W.J., Lauri G. Prediction of intestinal permeability. Adv. Drug Deliv. Rev. 54:2002;273-289
64. Quiñones C., et al. Prediction of drug half-life values of antihistamines based on the CODES/neural network model. Quant. Struct. Act. Relat. 19:2000;448-454
65. Niwa T. Using general regression and probabilistic neural networks to Predict human intestinal absorption with topological descriptors derived from two-dimensional chemical structures. J. Chem. Inf. Comput. Sci. 43:2003;113-119
66. Molnár L., Keser? G.M. A neural network based virtual screening of cytochrome P450 3A4 inhibitors. Bioorg. Med. Chem. Lett. 12:2002;419-421
67. Korolev D. Modeling of human cytochrome P450-mediated drug Metabolism using unsupervised machine learning approach. J. Med. Chem. 46:2003;3631-3643
68. Mazzatorta P., et al. Modeling toxicity by using supervised Kohonen neural networks. J. Chem. Inf. Comput. Sci. 43:2003;485-492
69. Feng J., et al. Predictive toxicology: benchmarking molecular descriptors and statistical methods. J. Chem. Inf. Comput. Sci. 43:2003;1463-1470
70. Greene N. Computer systems for the prediction of toxicity: an update. Adv. Drug Deliv. Rev. 54:2002;417-431
71. Basak S.C., et al. Use of statistical and neural net approaches in predicting toxicity of chemicals. J. Chem. Inf. Comput. Sci. 40:2000;885-890
72. Burden F.R., Winkler D.A. A quantitative structure-activity relationships model for the acute toxicity of substituted benzenes to Tetrahymena pyriformis using Bayesian-regularized neural networks. Chem. Res. Toxicol. 13:2000;436-440
73. Espinosa G., et al. An integrated SOM-fuzzy ARTMAP neural system for the evaluation of toxicity. J. Chem. Inf. Comput. Sci. 42:2002;343-359
74. Kaiser K.L.E. Neural networks for effect prediction in environmnetal and health issues using large datasets. QSAR Comb. Sci. 22:2003;185-190
75. Agrafiotis D.K., Lobanov V.S. Nonlinear mapping networks. J. Chem. Info. Comput. Sci. 40:2000;1356-1362
76. Rassokhin D.N., et al. Nonlinear mapping of massive data sets by fuzzy clustering and neural networks. J. Comput. Chem. 22:2001;373-386
77. Agrafiotis D.K., et al. Multidimensional scaling and visualization of large molecular similarity tables. J. Comput. Chem. 22:2001;488-500
78. Lobanov V.S., Agrafiotis D.K. Combinatorial networks. J. Mol. Graph. Model. 19:2001;571-578
79. Agrafiotis D.K., Lobanov V.S. Multidimensional scaling of combinatorial libraries without explicit enumeration. J. Comput. Chem. 22:2001;1712-1722
80. Agrafiotis D.K., et al. On the use of neural network ensembles in QSAR and QSPR. J. Chem. Info. Comput. Sci. 42:2002;903-911
81. Byvatov, E. et-al. Comparison of support vector machine and artificial neural network systems for drug/nondrug classification. J. Chem. Inf. Comput. Sci. (in press)
82. Zuegge J., et al. A fast virtual screening filter for cytochrome P450 3A4 inhibition liability of compound libraries. Quant. Struct. Act. Relat. 21:2002;249-256